Equities

Zhejiang Gongdong Medical Technology Co Ltd

605369:SHH

Zhejiang Gongdong Medical Technology Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (CNY)29.93
  • Today's Change-1.31 / -4.19%
  • Shares traded485.11k
  • 1 Year change-27.08%
  • Beta1.4526
Data delayed at least 15 minutes, as of Sep 13 2024 08:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in CNYIncome statement in CNYView more

Year on year Zhejiang Gongdong Medical Technology Co Ltd's revenues fell -33.61% from 1.47bn to 975.08m. This along with an increase in the cost of goods sold expense has contributed to a reduction in net income from 326.05m to 109.13m, a -66.53% decrease.
Gross margin32.48%
Net profit margin14.77%
Operating margin16.32%
Return on assets8.40%
Return on equity9.89%
Return on investment9.71%
More ▼

Cash flow in CNYView more

In 2023, cash reserves at Zhejiang Gongdong Medical Technology Co Ltd fell by 305.56m. However, the company earned 185.39m from its operations for a Cash Flow Margin of 19.01%. In addition the company used 397.43m on investing activities and also paid 95.80m in financing cash flows.
Cash flow per share--
Price/Cash flow per share--
Book value per share10.57
Tangible book value per share8.34
More ▼

Balance sheet in CNYView more

Zhejiang Gongdong Medical Technology Co Ltd appears to have a strong balance sheet with enough cash in the capital structure to pay down 100% of the liabilities.
Current ratio3.40
Quick ratio3.00
Total debt/total equity0.0553
Total debt/total capital0.0521
More ▼

Growth rates in CNY

Year on year, growth in dividends per share increased 166.67% while earnings per share excluding extraordinary items fell by -66.67%. The positive trend in dividend payments is noteworthy since very few companies in the Medical Equipment & Supplies industry pay a dividend. Additionally, five year annualized earnings per share growth is in-line with the industry average relative to its peers.
Div yield(5 year avg)--
Div growth rate (5 year)--
Payout ratio (TTM)20.82%
EPS growth(5 years)-0.8252
EPS (TTM) vs
TTM 1 year ago
52.34
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.